Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake
Date Insider Transaction Shares Price Value Owned after
2018-06-25 Requadt Scott Director Conversion +678,891 2,962,325
2018-06-25 Requadt Scott Director Conversion · Series A Preferred Stock −9,435,150 0
2018-06-25 Requadt Scott Director Conversion · Series B Preferred Stock −2,805,179 0
2018-06-25 SVLSF VI, LLC 10% owner Conversion +2,207,843 2,207,843
2018-06-25 SVLSF VI, LLC 10% owner Conversion +75,591 75,591
2018-06-25 SVLSF VI, LLC 10% owner Conversion +437,611 2,645,454
2018-06-25 SVLSF VI, LLC 10% owner Conversion +14,982 90,573
2018-06-25 SVLSF VI, LLC 10% owner Conversion · Series A Preferred Stock −9,122,809 0
2018-06-25 SVLSF VI, LLC 10% owner Conversion · Series A Preferred Stock −312,341 0
2018-06-25 SVLSF VI, LLC 10% owner Conversion · Series B Preferred Stock −1,808,211 0
2018-06-25 SVLSF VI, LLC 10% owner Conversion · Series B Preferred Stock −61,908 0
2018-06-25 Clarus Lifesciences III, L.P. 10% owner Conversion +2,283,434 2,283,434
2018-06-25 Clarus Lifesciences III, L.P. 10% owner Conversion +678,891 2,962,325
2018-06-25 Clarus Lifesciences III, L.P. 10% owner Conversion · Series A Preferred Stock −9,435,150 0
2018-06-25 Clarus Lifesciences III, L.P. 10% owner Conversion · Series B Preferred Stock −2,805,179 0
2018-06-25 Booth Bruce Director Conversion +806,711 806,711
2018-06-25 Booth Bruce Director Conversion +3,044,579 3,851,290
2018-06-25 Booth Bruce Director Conversion +905,188 4,756,478
2018-06-25 Booth Bruce Director Conversion · Series Seed Preferred Stock −3,333,333 0
2018-06-25 Booth Bruce Director Conversion · Series A Preferred Stock −12,580,199 0

Page 16 of 17 · 322 trades